original ) (raw )The type 1 insulin-like growth factor receptor is over-expressed in bladder cancer
Andrew Protheroe
Bju International, 2007
View PDFchevron_right
The Insulin-Like Growth Factor Receptor I Promotes Motility and Invasion of Bladder Cancer Cells through Akt- and Mitogen-Activated Protein Kinase-Dependent Activation of Paxillin
Michela Spinelli
The American Journal of Pathology, 2010
View PDFchevron_right
Involvement of the insulin-like growth factor I receptor and its downstream antiapoptotic signaling pathway is revealed by dysregulated microRNAs in bladder carcinoma
Ji-Fan Lin
Urological Science, 2014
View PDFchevron_right
Differential Expression of IGF-I Transcripts in Bladder Cancer
Michael Koutsilieris
Anticancer research, 2018
View PDFchevron_right
Does the IGF axis influence EMT to play a role in bladder cancer progression
Sophie Tang
2019
View PDFchevron_right
Comparison of hypoxia transcriptome in vitro with in vivo gene expression in human bladder cancer
David Cranston
British journal of cancer, 2005
View PDFchevron_right
Hypoxia-Inducible Factor 1? Expression Correlates with Angiogenesis and Unfavorable Prognosis in Bladder Cancer
Andreas C . Lazaris
European Urology, 2004
View PDFchevron_right
Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in human bladder tumors and cell lines
David Cranston
Clinical cancer research : an official journal of the American Association for Cancer Research, 2001
View PDFchevron_right
Metabolomics, Transcriptomics and Functional Glycomics Reveals Bladder Cancer Cells Plasticity and Enhanced Aggressiveness Facing Hypoxia and Glucose Deprivation
Paula Paulo
2021
View PDFchevron_right
The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial vs invasive bladder cancer
Charles Wykoff
2002
View PDFchevron_right
Expression and Significance of Vascular Endothelial Growth Factor Receptor 2 in Bladder Cancer
rizwan masood
Journal of Urology, 2006
View PDFchevron_right
The Sirenic Links between Diabetes, Obesity, and Bladder Cancer
Richard Bryan
International Journal of Molecular Sciences, 2021
View PDFchevron_right
High insulin-like growth factor mRNA-binding protein 3 (IMP3) protein expression is associated with poor survival in muscle-invasive bladder cancer
Agnes Bankfalvi
BJU International, 2012
View PDFchevron_right
Expression of the Endothelin Axis in Noninvasive and Superficially Invasive Bladder Cancer: Relation to Clinicopathologic and Molecular Prognostic Parameters
Stephan Kruck
European Urology, 2009
View PDFchevron_right
Diabetes Mellitus is Associated with High Grade and High Stage in Urinary Bladder Cancer
Ozan HORSANALI
View PDFchevron_right
Novel robust biomarkers for human bladder cancer based on activation of intracellular signaling pathways
Anastasia A. Zabolotneva
Oncotarget, 2014
View PDFchevron_right
Identification of a Hypoxia-Related Signature for Predicting Prognosis and the Immune Microenvironment in Bladder Cancer
liangliang ren
Frontiers in Molecular Biosciences, 2021
View PDFchevron_right
Insulin-induced proliferation of bladder cancer cells is mediated through activation of the epidermal growth factor system
Boe Sorensen
FEBS Journal, 2006
View PDFchevron_right
The effect of hypoxia on PD-L1 expression in bladder cancer
Tim Illidge
BMC Cancer, 2021
View PDFchevron_right
The association between serum hypoxia inducible factor-1α level and urothelial bladder cancer: A preliminary study
Gerhard Situmorang
Archivio italiano di urologia, andrologia, 2023
View PDFchevron_right
Identification of hypoxic gene-signature as a prognostic and predictive biomarker to determine effective therapy in high risk bladder cancer patients
Claudia Chavez-Munoz
Translational andrology and urology, 2018
View PDFchevron_right
Evaluation of IGF-2 Gene Expression in Urine and its Potential Use as Biomarker for Bladder Cancer
Awad Elabd
Benha Journal of Applied Sciences, 2021
View PDFchevron_right
Insulin Receptor Isoforms A and B as well as Insulin Receptor Substrates-1 and -2 Are Differentially Expressed in Prostate Cancer
Fausto Machicao
PLoS ONE, 2012
View PDFchevron_right
The Insulin Receptor: A New Target for Cancer Therapy
Antonino Belfiore
Frontiers in Endocrinology, 2011
View PDFchevron_right
Insulin and IGFs in renal cancer risk and progression
Anna M. Czarnecka
Endocrine-Related Cancer, 2015
View PDFchevron_right
Large-scale Real-time Reverse Transcription-PCR Approach of Angiogenic Pathways in Human Transitional Cell Carcinoma of the Bladder: Identification of VEGFA as a Major Independent Prognostic Marker
Rosette Lidereau
European Urology, 2009
View PDFchevron_right
Validation of the type 1 insulin-like growth factor receptor as a therapeutic target in renal cancer
Andrew Protheroe
Molecular Cancer Therapeutics, 2009
View PDFchevron_right
Evaluation of IGF2, KRT14, and KRT20 as Urinary Biomarkers in Patients with Bladder Cancer
masoud khalili
Reports of Biochemistry and Molecular Biology
View PDFchevron_right
Systematic Survey of the Role of IGF in the Link Between Diabetes and Cancer
Nirupama Devanathan
Indiana University journal of undergraduate research, 2018
View PDFchevron_right
Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression
Russell Leek
British journal of cancer, 2005
View PDFchevron_right
The Role of Hypoxia-Inducible Factor-1 in Three-dimensional Tumor Growth, Apoptosis, and Regulation by the Insulin-Signaling Pathway
Ian Stratford
Cancer Research, 2005
View PDFchevron_right
IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder
Ting-feng Wu
Journal of Clinical Pathology, 2013
View PDFchevron_right
Role of the angiogenic components, VEGFA, FGF2, OPN and RHOC, in urothelial cell carcinoma of the urinary bladder
Demetrios Spandidos
2012
View PDFchevron_right
Insulin and insulin-like growth factors act as renal cell cancer intratumoral regulators
Anna M. Czarnecka
Journal of Cell Communication and Signaling, 2019
View PDFchevron_right
The Evaluation of Vascular Endothelial Growth Factor A (VEGFA) and VEGFR2 Receptor as Prognostic Biomarkers in Bladder Cancer
Laila Benbacer
Diagnostics, 2023
View PDFchevron_right